These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 666968

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Monochemotherapy (Adriamycin) for metastatic breast cancer in progression after sequential hormone-chemotherapy (MAP and CMF). Pilot study.
    Pannuti F, Rossi AP, Di Marco AR, Fruet F, Lelli G, Strocchi E, Rocchetta G, Piana E, Martoni A.
    Panminerva Med; 1981; 23(1):25-8. PubMed ID: 7290722
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone.
    Frederiksen PL, Joergensen ST, Roesdahl K, Thomsen J, Mouridsen HT.
    Cancer Treat Rep; 1978 Mar; 62(3):449-50. PubMed ID: 348314
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combination chemotherapy with cyclophosphamide (NSC-26 271), methotrexate (NSC-740), and prednisolone (NSC-9 900) (CMP protocol), for metastatic breast cancer.
    Umsawasdi T, Nilprabhassorn P.
    J Med Assoc Thai; 1978 Mar; 61(3):158-61. PubMed ID: 660008
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Alternating cyclical hormonal-cytotoxic combination chemotherapy in postmenopausal patients with breast cancer. An EORTC trial.
    Heuson JC, Sylvester R, Engelsman E.
    Eur J Cancer (1965); 1980 Mar; Suppl 1():113-7. PubMed ID: 7032920
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chemotherapy of breast cancer.
    Mitchell MS.
    Conn Med; 1975 Jan; 39(1):4-5. PubMed ID: 1109851
    [No Abstract] [Full Text] [Related]

  • 13. Cyclic combination chemotherapy for metastatic breast cancer.
    Biran S, Krasnokuki D, Hochman A, Brufman G.
    Isr J Med Sci; 1977 Jun; 13(6):582-6. PubMed ID: 885710
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Efficacy of doxorubicin (adriamycin) in disseminated forms of breast cancer].
    Trofimova NB, Gorbunova VA.
    Antibiotiki; 1983 Aug; 28(8):625-8. PubMed ID: 6638976
    [Abstract] [Full Text] [Related]

  • 16. [Role and limitations of chemotherapy in breast cancer].
    Cattan A, Pourny C.
    Sem Hop; 1983 Aug; 51(31-34):2119-21. PubMed ID: 170687
    [No Abstract] [Full Text] [Related]

  • 17. [Evaluation of the toxicity of precautional chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in carcinoma of the breast in the first 700 treatment cycles].
    Sismondi P, Zola P, Galletto L, De Giovanni D, Giardina G.
    Minerva Ginecol; 1979 Aug; 31(7-8):563-8. PubMed ID: 481814
    [No Abstract] [Full Text] [Related]

  • 18. [Adjuvant chemotherapy in breast cancer].
    Senn HJ.
    Dtsch Med Wochenschr; 1981 Nov 27; 106(48):1626-30. PubMed ID: 7030686
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Results of a prospective clinical trial comparing two cytotoxic regimes containing adriamycin in women with advanced breast cancer.
    Priestman TJ.
    Clin Oncol; 1975 Sep 27; 1(3):207-11. PubMed ID: 1212828
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.